Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients

Conclusions: Combined with riluzole, edaravone slows disease progression and is safe, but the effect is short-term. Bulbar symptoms respond better to combination therapy. The serum creatinine is helpful in monitoring disease progression.
Source: Annals of Indian Academy of Neurology - Category: Neurology Authors: Source Type: research